Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Fradet

Showing results (21-30 of 110) with videos related to

Pageof 11
Sort By:
L'Union Medicale Du Canada|July 1, 1977
[Immunologic activities of lymphocytes in rats. IV. Chronologic functional variation of lymphocytes of the thoracic duct]Y Fradet, J McNicoll, F Daguillard
L'Union Medicale Du Canada|September 1, 1985
[The use of multiparameter flow cytometry in the detection and evaluation of human bladder tumors]Y Fradet, M Tardif, C Parent-Vaugeois
Tissue Antigens|August 1, 1981
Influence of HLA-A and HLA-B cross-reactive antigen matching on kidney graft survivalR Roy, Y Fradet, J G Lachance
British Journal of Urology|June 20, 1998
The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic indexP Allard, P Bernard, Y Fradet, et al.
Nutrition and Cancer|January 1, 1997
Dietary energy and nutrients in relation to preclinical prostate cancerF Meyer, I Bairati, Y Fradet, et al.
The Journal of Urology|March 19, 1999
Downward trend in prostate cancer mortality in Quebec and CanadaF Meyer, L Moore, I Bairati, et al.
The Journal of Biological Chemistry|March 22, 1996
MAUB is a new mucin antigen associated with bladder cancerA Bergeron, S Champetier, H LaRue, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 1, 1996
[Clinical value of the study of proliferation and cell activation antigens with flow cytometry in bladder cancer]L Lacombe, J Gauthier, L Lafleur, et al.
Cancer Research|January 15, 1990
Clinical cancer progression in urinary bladder tumors evaluated by multiparameter flow cytometry with monoclonal antibodies. Laval University Urology GroupY Fradet, M Tardif, L Bourget, et al.
Anticancer Research|March 1, 1990
The assessment of disease aggressivity in stage D2 prostate cancer patients (review)M Koutsilieris, B Laroche, M Thabet, et al.
Pageof 11

Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
L'Union Medicale Du Canada|July 1, 1977
[Immunologic activities of lymphocytes in rats. IV. Chronologic functional variation of lymphocytes of the thoracic duct]Y Fradet, J McNicoll, F Daguillard
L'Union Medicale Du Canada|September 1, 1985
[The use of multiparameter flow cytometry in the detection and evaluation of human bladder tumors]Y Fradet, M Tardif, C Parent-Vaugeois
Tissue Antigens|August 1, 1981
Influence of HLA-A and HLA-B cross-reactive antigen matching on kidney graft survivalR Roy, Y Fradet, J G Lachance
British Journal of Urology|June 20, 1998
The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic indexP Allard, P Bernard, Y Fradet, et al.
Nutrition and Cancer|January 1, 1997
Dietary energy and nutrients in relation to preclinical prostate cancerF Meyer, I Bairati, Y Fradet, et al.
The Journal of Urology|March 19, 1999
Downward trend in prostate cancer mortality in Quebec and CanadaF Meyer, L Moore, I Bairati, et al.
The Journal of Biological Chemistry|March 22, 1996
MAUB is a new mucin antigen associated with bladder cancerA Bergeron, S Champetier, H LaRue, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 1, 1996
[Clinical value of the study of proliferation and cell activation antigens with flow cytometry in bladder cancer]L Lacombe, J Gauthier, L Lafleur, et al.
Cancer Research|January 15, 1990
Clinical cancer progression in urinary bladder tumors evaluated by multiparameter flow cytometry with monoclonal antibodies. Laval University Urology GroupY Fradet, M Tardif, L Bourget, et al.
Anticancer Research|March 1, 1990
The assessment of disease aggressivity in stage D2 prostate cancer patients (review)M Koutsilieris, B Laroche, M Thabet, et al.
Pageof 11